Twist Bioscience Corporation (TWST) Misses Q2 EPS by 1c, Revenues Beat; Raises FY21 Revenues Guidance Above Consensus

Twist Bioscience Reports Second Quarter Fiscal 2021 Financial Results

-- Revenue Growth of 62% over Fiscal 2020 Second Quarter --

-- Order Growth of 69% Year over Year --

-- Gross Margin of 39% for the Quarter --

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the second quarter of fiscal 2021 ended March 31, 2021.

The second quarter of our fiscal year... More